Picomolar Inhibition of Plasmepsin V, an Essential Malaria Protease, Achieved Exploiting the Prime Region.
Malaria is an infectious disease caused by Plasmodium parasites. It results in an annual death-toll of ~ 600,000. Resistance to all medications currently in use exists, and novel antimalarial drugs are urgently needed. Plasmepsin V (PmV) is an essential Plasmodium protease and a highly promising ant...
Main Authors: | Luca Gambini, Luca Rizzi, Alessandro Pedretti, Orazio Taglialatela-Scafati, Mario Carucci, Andrea Pancotti, Corinna Galli, Martin Read, Emanuele Giurisato, Sergio Romeo, Ilaria Russo |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4643876?pdf=render |
Similar Items
-
Correction: Picomolar Inhibition of Plasmepsin V, an Essential Malaria Protease, Achieved Exploiting the Prime Region.
by: Luca Gambini, et al.
Published: (2016-01-01) -
Experimental determination of the membrane topology of the Plasmodium protease Plasmepsin V.
by: Sarah J Tarr, et al.
Published: (2015-01-01) -
Sub-picomolar Inhibition of HIV-1 Protease with a Boronic Acid
by: Windsor, Ian William, et al.
Published: (2020) -
Assessment of Biological Role and Insight into Druggability of the Plasmodium falciparum Protease Plasmepsin V
by: Polino, Alexander J., et al.
Published: (2020) -
Antimalarial Phytochemicals Identification from Euphorbia Hirta against Plasmepsin Protease: an In Silico Approach
by: Ashish P. Shah, et al.
Published: (2019-12-01)